LeMaitre Vascular Income Statement
LMAT / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
LeMaitre Vascular reported $250M in revenue and $58M in net income for FY2025. Revenue has grown at a 11.0% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M | $129.4M | $117.2M | $105.6M | $100.9M | $89.2M | $78.4M | $71.1M | $64.5M | $56.7M | $57.7M |
| Cost of Revenue | $71.1M | $69.0M | $66.4M | $56.8M | $53.0M | $44.7M | $37.4M | $31.6M | $30.2M | $26.2M | $24.2M | $22.7M | $19.4M | $15.9M | $17.5M |
| Gross Profit | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M | $84.6M | $79.9M | $73.9M | $70.7M | $62.9M | $54.2M | $48.4M | $45.1M | $40.9M | $40.2M |
| SG&A Expense | $42.0M | $36.3M | $31.8M | $28.7M | $25.5M | $22.5M | $19.1M | $17.7M | $17.0M | $14.4M | $14.0M | $13.9M | $12.6M | $11.0M | $11.2M |
| R&D Expense | $14.1M | $15.7M | $17.0M | $13.3M | $11.8M | $10.1M | $9.3M | $8.2M | $6.6M | $6.1M | $5.5M | $4.7M | $5.2M | $5.1M | $4.4M |
| Operating Income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M | $28.8M | $21.2M | $28.2M | $21.1M | $16.3M | $11.5M | $6.3M | $4.5M | $4.2M | $3.7M |
| Interest Expense | $5.2M | $205.0K | $0 | $0 | $2.2M | $1.3M | $0 | $2.0K | $21.0K | $14.0K | - | $5.0K | $12.0K | $1.0K | - |
| Income Tax | $17.4M | $12.8M | $9.4M | $6.9M | $7.4M | $6.1M | $3.7M | $5.5M | $3.9M | $5.7M | $3.7M | $2.4M | $1.1M | $1.4M | $1.6M |
| Net Income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M | $21.2M | $17.9M | $22.9M | $17.2M | $10.6M | $7.8M | $3.9M | $3.2M | $2.6M | $2.1M |
| EPS (Basic) | $1.36 | $1.96 | $1.36 | $0.94 | $1.27 | $1.05 | $0.91 | $1.18 | $0.91 | $0.57 | $0.44 | $0.24 | $0.21 | $0.17 | $0.14 |
| EPS (Diluted) | $1.34 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 | $0.42 | $0.23 | $0.20 | $0.16 | $0.13 |
| Shares Outstanding | 22.5M | 22.8M | 22.4M | 22.2M | 21.5M | 20.5M | 20.3M | 20.2M | 20.0M | 19.2M | 18.3M | 17.0M | 15.8M | 15.6M | 16.0M |
| Gross Margin | 71.5% | 68.6% | 65.7% | 64.9% | 65.6% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% | 69.1% | 68.1% | 69.9% | 72.0% | 69.7% |
| Operating Margin | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.3% | 18.1% | 26.7% | 20.9% | 18.3% | 14.7% | 8.9% | 7.0% | 7.5% | 6.4% |
| Profit Margin | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% | 9.9% | 5.5% | 5.0% | 4.5% | 3.7% |